CUSIP: 87164U201
Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,870,470
-
Share change
-
+2,133,481
-
Total reported value
-
$1,608,001
-
Price per share
-
$0.56
-
Number of holders
-
18
-
Value change
-
+$1,119,471
-
Number of buys
-
10
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2019
-
Previous quarter:
Q3 2018
Recent filing periods for CUSIP 87164U201:
Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q4 2018
As of 31 Dec 2018,
THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,870,470 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Third Security, LLC, RENAISSANCE TECHNOLOGIES LLC, Anson Funds Management LP, BOOTHBAY FUND MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, 683 Capital Management, LLC, Vanguard Group Inc, and BlackRock Inc..
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.